|
EP3769082A1
|
|
Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence
|
|
WO2019180507A1
|
|
Methods of cultivating bordetella species
|
|
AU2015228542A1
|
|
Immunogenic compositions
|
|
AU2014202243A1
|
|
Antigen-adjuvant compositions and methods
|
|
WO2014089706A1
|
|
Methods for assessing immunogenicity
|
|
US2015150964A1
|
|
Herpesvirus compositions and related methods
|
|
CN104039348A
|
|
Method For Formulating A Vaccine Containing At Least Two Antigens Capable Of Adsorbing Onto Aluminium Oxyhydroxide
|
|
CN103501808A
|
|
Composition for immunization against streptococcus pneumoniae
|
|
WO2012065262A1
|
|
Expression, purification and refolding of recombinant chlamydia proteins, compositions and related methods
|
|
WO2012065263A1
|
|
Immunogenic compositions
|
|
AU2011224126A1
|
|
Tumor antigens BFA5 for prevention and/or treatment of cancer
|
|
AU2011202678A1
|
|
Immunogenic PcpA polypeptides and uses thereof
|
|
US2011229517A1
|
|
System and process for producing multi-component biopharmaceuticals
|
|
CN102939105A
|
|
Immunogenic compositions and related methods
|
|
WO2011075823A1
|
|
Immunogenic compositions
|
|
BR112012002429A2
|
|
porphyromonas gingivalis polypeptides
|
|
CA2697804A1
|
|
System and process for producing multi-component biopharmaceuticals
|
|
WO2010071986A1
|
|
Modified steptococcus pneumonia pneumolysin (ply) polypeptides
|
|
CN102257134A
|
|
Methods using ion exchange and gel filtration chromatography for poxvirus purification
|
|
MX2010008514A
|
|
Assay for diagnosing streptococcus pneumoniae.
|
